HPLC quantitative analysis of enzymes involve in the action of any bioactive agents on Ebola virus
International Conference and Exhibition on Advances in HPLC & Chromatography Techniques
March 14-15, 2016 London, UK

Bello Hassan Onimisi

Olabisi Onabanjo University, Nigeria

Posters & Accepted Abstracts: Pharm Anal Acta

Abstract:

The use of drugs to combat diseases in man has been a practice dated back to creation. In recent years, scientist are beginning to realize the effect of some of these drugs on man. This has prompted a more diversion into natural products especially in Asia and in Africa. Even with this, scientist and orthodox medicine are still having problems in the dosage of this medicine. In recent work that I carried out in Mayer and Baker Laboratory and Faculty of Pharmacy in Olabisi Onabanjo University in Sagamu on certain enzyme (on going work), I have come to understand that the allosteric site of some enzymes can induce chemical substances that have pharmacological activities against some diseases if the appropriate substrate is allowed to bind to it. This has lead me to think that somehow there are enzymes that can be term to be a pharmco-enzymes just like I have also discovered pharmaco-transmitters in our other works responsible for healing actions in most diseases. These enzymes would open one gate and would possible dominate biotechnology of the future most especially in nutraceuticals and pharmaceutical industry. Since these enzymes are sensitive, sensitive methods especially HPLC is needed for the analysis.

Biography :

Email: hassanbello2001@yahoo.com